Inte:Ligand and Molecular Networks Announce the Integration of CORINA into the Virtual Library Generation Platform ILIB DIVERSE.

VIENNA, Austria & ERLANGEN, Germany -- Inte:Ligand and Molecular Networks today announce the integration of CORINA, the industry leading software for the generation of three-dimensional molecular models, into ILIB DIVERSE, the high quality virtual compound library generation platform of Inte:Ligand. The two companies are also announcing their intention to share complementary technology for mutual benefit in the future.

ILIB DIVERSE generates libraries of drug-like chemical compounds by assembling pre-defined building blocks. The resulting compounds are filtered based on their reactivity profile and a series of standard physicochemical properties. By integrating CORINA into ILIB DIVERSE, high-quality virtual libraries of three-dimensional compounds can be calculated seamlessly.

"We appreciate and value our collaboration with Molecular Networks. The integration of CORINA into our product is a logical step forward towards providing a complete solution for the enumeration and proactive analysis of chemical libraries", state Prof. Thierry Langer, Inte:Ligand's CEO and Dr. Gerhard Wolber, head of the Computer Science Group. Dr. Jean-Pierre Kocher, CEO of Molecular Networks, adds, "CORINA enables ILIB DIVERSE to produce virtual libraries that are readily available for docking experiments or 3D QSAR analysis. We are excited about the outcome of this collaboration. I'm confident that this will have an immediate benefit for ILIB DIVERSE users."

About Inte:Ligand

Inte:Ligand GmbH (http://www.inteligand.com) is specialized in developing software and offering contract research for rational in silico drug discovery. As a young and innovative company in the field of information driven drug discovery, Inte:Ligand was founded with the idea of incorporating extensive scientific experience into intuitive and usable software products. Inte:Ligand's products and services aim to improve the efficiency of R&D processes whilst simultaneously reducing development costs by using computer simulations.

About Molecular Networks

Molecular Networks (http://www.mol-net.com) is a chemoinformatics company that provides tools, consulting and development services to chemical, pharmaceutical and biotechnology companies. The company's product portfolio includes twenty applications that are used by over one hundred customers and partners worldwide. Currently, the company is directing its expertise and proprietary technology to expand its business activities in the areas of the prediction of chemical reactivity and synthetic accessibility of compounds. A new product range covering these areas will be available from 2005.